Anushka, a seasoned investment analyst and financial writer, delves deep into the stock market's intricacies. Her journey began as an equity research intern after earning her bachelor's in commerce. She's on a mission to empower investors through her articles featured on prominent financial media platforms. Currently pursuing the CFA program, she aims to empower investors with essential knowledge for sustained financial prosperity.
Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.
/Apple%20Logo%20on%20Store%20Front.jpg)
While tech giant Apple kicked off 2024 on a rocky note, here’s why an increasing number of Wall Street analysts are warming up to the stock lately.
/Development%20Environment%20Laptop.jpg)
As the demand for cybersecurity solutions rises, here are two ‘Strong Buy’-rated cybersecurity growth stocks investors could grab now for potential gains.
/shutterstock_2151224461.jpg)
Amidst the rising tide of AI optimism, analysts believe these three AI stocks are well-poised to ride the wave of AI innovation in the latter part of this year.
With silver poised to rally even higher after taking out a critical technical level, here are three 'Strong Buy'-rated silver stocks for dividend investors.
As the demand for data centers continues to skyrocket, this battery storage stock could offer significant upside potential.
As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.
With the tech landscape increasingly dominated by AI stocks, can Palantir break out in the back of this year?
As psychedelic treatments gain traction, analysts predict triple-digit upside for this small-cap biotech stock.
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying.
